ImmunomeInc Property Plant And Equipment Net from 2010 to 2024
IMNM Stock | USD 14.94 0.23 1.56% |
Property Plant And Equipment Net | First Reported 2010-12-31 | Previous Quarter 3.6 M | Current Value 2 M | Quarterly Volatility 621.6 K |
Check ImmunomeInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ImmunomeInc main balance sheet or income statement drivers, such as Net Interest Income of 2.9 M, Interest Income of 2.9 M or Depreciation And Amortization of 689.9 K, as well as many exotic indicators such as Price To Sales Ratio of 12.12, Dividend Yield of 0.0 or PTB Ratio of 1.86. ImmunomeInc financial statements analysis is a perfect complement when working with ImmunomeInc Valuation or Volatility modules.
ImmunomeInc | Property Plant And Equipment Net |
Latest ImmunomeInc's Property Plant And Equipment Net Growth Pattern
Below is the plot of the Property Plant And Equipment Net of ImmunomeInc over the last few years. It is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production. ImmunomeInc's Property Plant And Equipment Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ImmunomeInc's overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Net | 10 Years Trend |
|
Property Plant And Equipment Net |
Timeline |
ImmunomeInc Property Plant And Equipment Net Regression Statistics
Arithmetic Mean | 1,960,033 | |
Geometric Mean | 1,863,358 | |
Coefficient Of Variation | 31.71 | |
Mean Deviation | 371,884 | |
Median | 2,082,000 | |
Standard Deviation | 621,587 | |
Sample Variance | 386.4B | |
Range | 2.8M | |
R-Value | (0.11) | |
Mean Square Error | 410.9B | |
R-Squared | 0.01 | |
Significance | 0.69 | |
Slope | (15,473) | |
Total Sum of Squares | 5.4T |
ImmunomeInc Property Plant And Equipment Net History
About ImmunomeInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include ImmunomeInc income statement, its balance sheet, and the statement of cash flows. ImmunomeInc investors use historical funamental indicators, such as ImmunomeInc's Property Plant And Equipment Net, to determine how well the company is positioned to perform in the future. Although ImmunomeInc investors may use each financial statement separately, they are all related. The changes in ImmunomeInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ImmunomeInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ImmunomeInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ImmunomeInc. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Property Plant And Equipment Net | 3.6 M | 2 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as ImmunomeInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of ImmunomeInc Correlation against competitors. To learn how to invest in ImmunomeInc Stock, please use our How to Invest in ImmunomeInc guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for ImmunomeInc Stock analysis
When running ImmunomeInc's price analysis, check to measure ImmunomeInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunomeInc is operating at the current time. Most of ImmunomeInc's value examination focuses on studying past and present price action to predict the probability of ImmunomeInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunomeInc's price. Additionally, you may evaluate how the addition of ImmunomeInc to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Stocks Directory Find actively traded stocks across global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is ImmunomeInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunomeInc. If investors know ImmunomeInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunomeInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (17.58) | Revenue Per Share 0.427 | Quarterly Revenue Growth (0.56) | Return On Assets (0.15) | Return On Equity (1.55) |
The market value of ImmunomeInc is measured differently than its book value, which is the value of ImmunomeInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunomeInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunomeInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunomeInc's market value can be influenced by many factors that don't directly affect ImmunomeInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunomeInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunomeInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunomeInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.